165 related articles for article (PubMed ID: 32427378)
1. Impact of diabetes mellitus and hemoglobin A1c level on outcomes among Chinese patients with acute coronary syndrome.
Xiong R; He L; Du X; Dong JZ; Ma CS
Clin Cardiol; 2020 Jul; 43(7):723-731. PubMed ID: 32427378
[TBL] [Abstract][Full Text] [Related]
2. Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study.
Zhang L; Xu C; Liu J; Bai X; Li R; Wang L; Zhou J; Wu Y; Yuan Z
Cardiovasc Diabetol; 2019 Apr; 18(1):52. PubMed ID: 31014348
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of Admission Mean Corpuscular Volume for Major Adverse Cardiovascular Events following Stent Implantation in Nondiabetic and Diabetic Patients with Acute Coronary Syndrome.
Cheng L; Zhang L; Liu J; Li W; Bai X; Li R; Li B; Wang L; Zhou J; Wu Y; Yuan Z
Dis Markers; 2020; 2020():7054596. PubMed ID: 32733619
[TBL] [Abstract][Full Text] [Related]
4. Fibrinogen is associated with glucose metabolism and cardiovascular outcomes in patients with coronary artery disease.
Liu SL; Wu NQ; Shi HW; Dong Q; Dong QT; Gao Y; Guo YL; Li JJ
Cardiovasc Diabetol; 2020 Mar; 19(1):36. PubMed ID: 32192491
[TBL] [Abstract][Full Text] [Related]
5. Adjustment of the GRACE score by HemoglobinA1c enables a more accurate prediction of long-term major adverse cardiac events in acute coronary syndrome without diabetes undergoing percutaneous coronary intervention.
Liu XJ; Wan ZF; Zhao N; Zhang YP; Mi L; Wang XH; Zhou D; Wu Y; Yuan ZY
Cardiovasc Diabetol; 2015 Aug; 14():110. PubMed ID: 26285575
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of HbA1c for in-hospital and short-term mortality in patients with acute coronary syndrome: a systematic review and meta-analysis.
Pan W; Lu H; Lian B; Liao P; Guo L; Zhang M
Cardiovasc Diabetol; 2019 Dec; 18(1):169. PubMed ID: 31829179
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Hemoglobin A1c Levels in Postmenopausal Diabetic Patients Undergoing Percutaneous Coronary Intervention (PCI) for Acute Coronary Syndrome.
Lao Y; Feng L; Yuan Y; Zhang J; Huang X; Li M; Wu Z
Med Sci Monit; 2018 Dec; 24():9399-9405. PubMed ID: 30587845
[TBL] [Abstract][Full Text] [Related]
8. Admission fasting plasma glucose is associated with in-hospital outcomes in patients with acute coronary syndrome and diabetes: findings from the improving Care for Cardiovascular Disease in China - Acute Coronary Syndrome (CCC-ACS) project.
Ye N; Yang L; Wang G; Bian W; Xu F; Ma C; Zhao D; Liu J; Hao Y; Liu J; Yang N; Cheng H;
BMC Cardiovasc Disord; 2020 Aug; 20(1):380. PubMed ID: 32819275
[TBL] [Abstract][Full Text] [Related]
9. [Value of glycosylated hemoglobin A1c and apolipoprotein A-1 ratio on predicting outcome of patients with acute coronary syndrome].
Wang YJ; Mu HN; Yang RY; Zhang WD; Wang XY; Wang SM; Ji FS; Dong J; Yu X
Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Jan; 51(1):38-44. PubMed ID: 36655240
[No Abstract] [Full Text] [Related]
10. The value of admission HbA(1c) level in diabetic patients with acute coronary syndrome.
Chan CY; Li R; Chan JY; Zhang Q; Chan CP; Dong M; Yan BP; Lam YY; Yu CM
Clin Cardiol; 2011 Aug; 34(8):507-12. PubMed ID: 21717470
[TBL] [Abstract][Full Text] [Related]
11. The role of the plasma glycosylated hemoglobin A1c/Apolipoprotein A-l ratio in predicting cardiovascular outcomes in acute coronary syndrome.
Song F; Zhou Y; Zhang K; Liang YF; He X; Li L
Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):570-578. PubMed ID: 33358616
[TBL] [Abstract][Full Text] [Related]
12. Impact of glycemic control status on patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
Li Y; Li X; Zhang Y; Zhang L; Wu Q; Bai Z; Si J; Zuo X; Shi N; Li J; Chu X
BMC Cardiovasc Disord; 2020 Jan; 20(1):36. PubMed ID: 32000678
[TBL] [Abstract][Full Text] [Related]
13. Increased risk of adverse cardiovascular events by strict glycemic control after percutaneous coronary intervention (HbA1c < 6.5% at 2 years) in type 2 diabetes mellitus combined with acute coronary syndrome: a 5-years follow-up study.
Yang T; Fu P; Chen J; Fu X; Xu C; Liu X; Niu T
Curr Med Res Opin; 2021 Sep; 37(9):1517-1528. PubMed ID: 34166166
[TBL] [Abstract][Full Text] [Related]
14. Diabetes and baseline glucose are associated with inflammation, left ventricular function and short- and long-term outcome in acute coronary syndromes: role of the novel biomarker Cyr 61.
Winzap P; Davies A; Klingenberg R; Obeid S; Roffi M; Mach F; Räber L; Windecker S; Templin C; Nietlispach F; Nanchen D; Gencer B; Muller O; Matter CM; von Eckardstein A; Lüscher TF
Cardiovasc Diabetol; 2019 Oct; 18(1):142. PubMed ID: 31672144
[TBL] [Abstract][Full Text] [Related]
15. Short-term and long-term adverse cardiovascular events across the glycaemic spectrum in patients with acute coronary syndrome: the Gulf Registry of Acute Coronary Events-2.
Alfaleh HF; Alhabib KF; Kashour T; Ullah A; Alsheikhali AA; Al Suwaidi J; Sulaiman K; Al Saif S; Almahmeed W; Asaad N; Amin H; Al-Motarreb A; Mimish L; Hersi A
Coron Artery Dis; 2014 Jun; 25(4):330-8. PubMed ID: 24525788
[TBL] [Abstract][Full Text] [Related]
16. Long-term prognostic impact of cystatin C on acute coronary syndrome octogenarians with diabetes mellitus.
Fu Z; Xue H; Guo J; Chen L; Dong W; Gai L; Liu H; Sun Z; Chen Y
Cardiovasc Diabetol; 2013 Nov; 12():157. PubMed ID: 24182196
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of fibrinogen in patients with coronary artery disease and prediabetes or diabetes following percutaneous coronary intervention: 5-year findings from a large cohort study.
Yuan D; Jiang P; Zhu P; Jia S; Zhang C; Liu Y; Liu R; Xu J; Tang X; Zhao X; Gao R; Yang Y; Xu B; Gao Z; Yuan J
Cardiovasc Diabetol; 2021 Jul; 20(1):143. PubMed ID: 34271936
[TBL] [Abstract][Full Text] [Related]
18. Impact of admission glycemia and glycosylated hemoglobin A1c on long-term clinical outcomes of non-diabetic patients with acute coronary syndrome.
Naito R; Miyauchi K; Ogita M; Kasai T; Kawaguchi Y; Tsuboi S; Konishi H; Okazaki S; Kurata T; Daida H
J Cardiol; 2014 Feb; 63(2):106-11. PubMed ID: 24011926
[TBL] [Abstract][Full Text] [Related]
19. Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China.
Hu C; Zhang J; Liu J; Liu Y; Gao A; Zhu Y; Zhao Y
Cardiovasc Diabetol; 2020 Jul; 19(1):116. PubMed ID: 32703284
[TBL] [Abstract][Full Text] [Related]
20. The Level of HbA1c Evaluates the Extent of Coronary Atherosclerosis Lesions and the Prognosis in Diabetes with Acute Coronary Syndrome.
Xu S; Zhou B; Zhou B; Zheng J; Xu Q; Wang B; Fu M; Meng Y
Comput Math Methods Med; 2022; 2022():7796809. PubMed ID: 35912151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
